Facio-Scapulo-Humeral Dystrophy clinical trials at University of California Health
2 in progress, 0 open to eligible people
Showing trials for
AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, in progress, not accepting new patients
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
at UCLA UCSD
Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
Sorry, not currently recruiting here
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)
at UC Irvine
Last updated: